To assess for any decrease in mortality associated with the use of the BNT162b2 booster
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 13 Dec 2021 New trial record
- 08 Dec 2021 Results published in the New England Journal of Medicine